Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Tokyo Tanabe describes agents for cardiovascular/respiratory disorders

Jan. 8, 1997

Beta-blockers underused

Jan. 7, 1997

P&U discontinues development of agent for DVT; Cytel regains development rights

Jan. 7, 1997

Andrx freed to market Dilacor XR bioequivalent

Jan. 3, 1997

bFGF enters clinical trials for PVD

Jan. 3, 1997

T Cell Sciences describes anti-CETP vaccines

Jan. 2, 1997

Nissan Chemical discloses novel cardiovascular agents

Jan. 2, 1997

FDA clears angiotensin II blocker from Ciba

Dec. 31, 1996

Combination antihypertensive product cleared by FDA

Dec. 31, 1996

Bayer launches sustained-release calcium antagonist in U.K.

Dec. 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...